Neurogene (NGNE) Stock Price & Financial Analysis
Neurogene Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Neurogene
What is the current stock price for NGNE?
As of the latest trading session, NGNE stock trades at $30.41. The 52-week range is $14.65–$37.27, with a day range of $29.66–$32.00.
What is the P/E ratio for NGNE?
The P/E ratio (Price-to-Earnings) for NGNE is shown in the Key Statistics section. This valuation metric helps compare Neurogene Inc. to industry peers.
Does NGNE pay dividends?
Neurogene does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NGNE?
Based on 8 analysts, the consensus for NGNE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NGNE?
Neurogene's market capitalization is $678.3M, classifying it as a small-cap company. Neurogene operates in the Healthcare sector within the Biotechnology industry.